Ophthalmic Drugs Market 2022 Analysis by Size, Share,
Ophthalmic Drugs Market
The global ophthalmic drugs market size is expected to grow from USD 50.62 billion in 2021 to USD 56.07 billion in 2022 at a compound annual growth rate (CAGR) of 10.8%. The growth of the market is mainly due to companies reorganizing their operations and recovering from the impact of COVID-19, which previously led to restrictive lockdown measures involving social distancing, remote working and closure of business activities which resulted in operational challenges. The ophthalmic drugs market is expected to reach USD 127.15 billion in 2026 with a CAGR of 22.7%.
The trade research company offers the Global Ophthalmic Drugs Market 2022 report in its research report store. This is the most comprehensive report available on this market and will help you gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the market size by region and country. It also compares historical and forecast market growth and highlights important trends and strategies that market players may adopt.
Buy the report directly here: https://www.thebusinessresearchcompany.com/sample.aspx?id=3617&type=smp
The ophthalmic drugs market includes sales of ophthalmic drugs and related services by entities (organizations, individual traders, and partnerships) that produce ophthalmic drugs to treat eye-related diseases. The ophthalmology drug industry includes establishments that produce pharmaceutical drugs to treat glaucoma diseases, anti-inflammatory and tear-stimulating drugs under dry eye drugs, and other drugs to treat retinal disorders and allergies . Some of the major eye medications include Eylea, Lucentis, Restasis, Vigamox, Azopt, and Lotemax.
Key players in the ophthalmic drugs market include Regeneron Pharmaceuticals, Inc., Novartis AG, AbbVie, Santen Pharmaceutical Co., F. Hoffmann-La Roche Ltd., Bausch Health Companies Inc., Bayer AG, Sumitomo Chemical Co ltd, Mitsubishi Tanabe Pharma Corporation and Horizon Therapeutics plc.
The countries covered in the global ophthalmic drugs market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru , Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, United Arab Emirates, United Kingdom, United States, Venezuela, Vietnam.
Regions covered in Global Ophthalmic Drugs Market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East & Africa .
Global Ophthalmic Drugs Market Segmentation:
1. Antiglaucoma drugs
2. Drugs for dry eyes
By Distribution Channel:
1. Hospital pharmacies
2. Retail pharmacies/ pharmacies
See more about the report at https://www.thebusinessresearchcompany.com/report/ophthalmology-drugs-global-market-report
The table of contents of the report includes
2. Structure of the report
3. Characteristics of Ophthalmology Drugs Market
4. Ophthalmology Drugs Market Product Analysis
5. Supply Chain of Ophthalmic Drugs Market
21. Major mergers and acquisitions in the ophthalmic drugs market
22. Market Context: Pharmaceutical Drugs Market
25. Copyright and Disclaimer
This report covers market trends and dynamics of Ophthalmology Drugs Market in major countries – Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The report also includes consumer surveys and various future opportunities for the market.
Request a sample of this report: https://www.thebusinessresearchcompany.com/sample.aspx?id=3617&type=smp
The Business Research Society
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]
Check out our blog: http://blog.tbrc.info/
And follow us on:
The Business Research Company (www.thebusinessresearchcompany.com) is a business information company that excels in business, market and consumer research. She has published over 3,000 industry reports, covering over 2,500 market segments and 60 geographies. The reports are based on 150,000 datasets, extensive secondary research and proprietary insights from interviews with industry leaders. Reports are updated with detailed analysis of the impact of COVID-19 on various markets.
This press release was published on openPR.